Related Experiment Videos
Coronary artery disease prevention: what's different for women?
J Bedinghaus1, L Leshan, S Diehr
1Department of Family and Community Medicine, Medical College of Wisconsin, Milwaukee 53226, USA. jbmd@mcw.edu
Insights
Cardiovascular disease is a major health risk for women. Proven primary and secondary prevention strategies, including exercise and medication, are effective but underused, especially in minority women.
Area of Science:
- Cardiology
- Preventive Medicine
- Women's Health
Background:
- Cardiovascular disease (CVD) is the leading cause of death and disability in women.
- Risk of CVD is often underestimated by women and healthcare providers.
- Primary and secondary prevention strategies are crucial for managing CVD in women.
Purpose of the Study:
- To review effective primary and secondary prevention strategies for coronary artery disease (CAD) in women.
- To highlight the underutilization of proven CVD treatments in women, particularly minority women.
- To emphasize the role of family physicians in promoting evidence-based CVD prevention.
Main Methods:
- Literature review of primary and secondary prevention measures for cardiovascular disease in women.
- Analysis of the efficacy of various interventions, including lifestyle modifications and pharmacotherapies.
- Examination of the current use and barriers to access for these treatments, with a focus on underserved populations.
Main Results:
- Exercise, hypertension treatment, smoking cessation, and aspirin therapy are effective for primary prevention of CAD in women.
- Lipid-lowering agents have shown benefits in secondary prevention, reducing recurrent myocardial infarction and mortality in women with established CAD.
- Proven secondary prevention measures like aspirin, beta blockers, ACE inhibitors, revascularization, and rehabilitation are underused, especially in minority women.
Conclusions:
- Effective primary and secondary prevention strategies for CVD in women exist.
- Underutilization of proven treatments, particularly in minority and underserved populations, is a significant concern.
- Family physicians should prioritize and promote evidence-based CVD prevention strategies for all women.
Abstract:
Cardiovascular disease is the leading cause of death in women, as well as an important cause of disability, although many women and their physicians underestimate the risk. Exercise, hypertension treatment, smoking cessation and aspirin therapy are effective measures for the primary prevention of coronary artery disease in women. The roles of lipid-lowering agents and hormone replacement therapy in primary prevention are not well established. In secondary prevention, hormone replacement therapy has not been effective in lowering the risk of recurrent myocardial infarction, but several lipid-lowering agents have been shown to reduce this risk and to lower mortality rates in women with known coronary artery disease. Other secondary prevention measures, including aspirin, beta blockers, angiotensin-converting enzyme inhibitors, revascularization and rehabilitation, have proven benefits in women but are underused, especially in minority women. Family physicians should emphasize the use of proven treatments, with particular attention given to underserved populations.